Cancer Research PRL Inhibitor Induces the Cleavage of p130Cas  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 2668-2675, July 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turley, J. M.
Right arrow Articles by Birchenall-Roberts, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turley, J. M.
Right arrow Articles by Birchenall-Roberts, M. C.

Vitamin E Succinate Inhibits Proliferation of BT-20 Human Breast Cancer Cells: Increased Binding of Cyclin A Negatively Regulates E2F Transactivation Activity

Jennifer M. Turley, Francis W. Ruscetti, Seong-Jin Kim, Tao Fu, F. Victoria Gou and Maria C. Birchenall-Roberts1

Laboratory of Leukocyte Biology, Division of Basic Sciences, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702 [J. M. T., F. W. R., F. V. G.]; Laboratory of Chemoprevention, National Cancer Institute, Bethesda, Maryland 20892 [S-J. K.]; and Intramural Research and Support Program, Science Application International Corporation-Frederick, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702 [M. C. B-R., T. F.]

Vitamin E succinate (VES) inhibited the proliferation of the estrogen receptor-negative human breast cancer cell line, BT-20, in the G1 phase of the cell cycle. The E2F proteins are integral transcriptional components in the regulation of cell growth. Overexpression of E2F-1 blocked the ability of VES to inhibit BT-20 cell growth, suggesting that VES regulation of E2F-1 activity leads to growth arrest of BT-20 cells. VES, although having little effect on E2F-1 steady-state protein levels, decreased E2F-1 phosphorylation and transactivation activity and increased cyclin A binding to E2F-1. GAL4-E2F-1 deletion mutant studies indicated that cyclin A negatively regulates E2F function. In VES-treated BT-20 cells, the cyclin A protein exhibited reduced kinase activity, which correlated with decreased steady-state levels and binding of cyclin-dependent kinase-2 to cyclin A and increased steady-state levels and binding of p21cip1 to cyclin A and cyclin-dependent kinase-2. The functional consequence of the negative regulatory effect of VES on E2F-1 function was shown by the ability of VES to inhibit the transcriptional activation of an E2F-1 responsive gene, c-myc. These studies show that VES induces growth inhibition of BT-20 cells through a mechanism that involves cyclin A-negative regulation of E2F-mediated transcription.

1 To whom requests for reprints should be addressed. Phone: (301) 846-1442; Fax: (301) 846-6862.

Received 12/13/96. Accepted 5/ 5/97.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
C. G. Havens, A. Ho, N. Yoshioka, and S. F. Dowdy
Regulation of Late G1/S Phase Transition and APCCdh1 by Reactive Oxygen Species
Mol. Cell. Biol., June 15, 2006; 26(12): 4701 - 4711.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-W. Shiau, J.-W. Huang, D.-S. Wang, J.-R. Weng, C.-C. Yang, C.-H. Lin, C. Li, and C.-S. Chen
{alpha}-Tocopheryl Succinate Induces Apoptosis in Prostate Cancer Cells in Part through Inhibition of Bcl-xL/Bcl-2 Function
J. Biol. Chem., April 28, 2006; 281(17): 11819 - 11825.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Donapaty, S. Louis, E. Horvath, J. Kun, S. M. Sebti, and M. P. Malafa
RRR-{alpha}-Tocopherol succinate down-regulates oncogenic Ras signaling.
Mol. Cancer Ther., February 1, 2006; 5(2): 309 - 316.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Stapelberg, N. Gellert, E. Swettenham, M. Tomasetti, P. K. Witting, A. Procopio, and J. Neuzil
{alpha}-Tocopheryl Succinate Inhibits Malignant Mesothelioma by Disrupting the Fibroblast Growth Factor Autocrine Loop: MECHANISM AND THE ROLE OF OXIDATIVE STRESS
J. Biol. Chem., July 8, 2005; 280(27): 25369 - 25376.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
K. N. Prasad
Multiple Dietary Antioxidants Enhance the Efficacy of Standard and Experimental Cancer Therapies and Decrease Their Toxicity
Integr Cancer Ther, December 1, 2004; 3(4): 310 - 322.
[Abstract] [PDF]


Home page
J. Am. Coll. Nutr.Home page
B. Kumar, M. N. Jha, W. C. Cole, J. S. Bedford, and K. N. Prasad
D-Alpha-Tocopheryl Succinate (Vitamin E) Enhances Radiation-Induced Chromosomal Damage Levels in Human Cancer Cells, but Reduces it in Normal Cells
J. Am. Coll. Nutr., August 1, 2002; 21(4): 339 - 343.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Weber, M. Lu, L. Andera, H. Lahm, N. Gellert, M. W. Fariss, V. Korinek, W. Sattler, D. S. Ucker, A. Terman, et al.
Vitamin E Succinate Is a Potent Novel Antineoplastic Agent with High Selectivity and Cooperativity with Tumor Necrosis Factor-related Apoptosis-inducing Ligand (Apo2 Ligand) in Vivo
Clin. Cancer Res., March 1, 2002; 8(3): 863 - 869.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
K. N. Prasad, W. C. Cole, B. Kumar, and K. C. Prasad
Scientific Rationale for Using High-Dose Multiple Micronutrients as an Adjunct to Standard and Experimental Cancer Therapies
J. Am. Coll. Nutr., October 1, 2001; 20(90005): 450S - 463.
[Abstract] [Full Text]


Home page
CirculationHome page
F. de Nigris, T. Youssef, S. Ciafre, F. Franconi, V. Anania, G. Condorelli, W. Palinski, and C. Napoli
Evidence for Oxidative Activation of c-Myc-Dependent Nuclear Signaling in Human Coronary Smooth Muscle Cells and in Early Lesions of Watanabe Heritable Hyperlipidemic Rabbits : Protective Effects of Vitamin E
Circulation, October 24, 2000; 102(17): 2111 - 2117.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
B. S. McIntyre, K. P. Briski, A. Gapor, and P. W. Sylvester
Antiproliferative and Apoptotic Effects of Tocopherols and Tocotrienols on Preneoplastic and Neoplastic Mouse Mammary Epithelial Cells
Experimental Biology and Medicine, September 1, 2000; 224(4): 292 - 301.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
T. J. Moran, S. Gray, C. A. Mikosz, and S. D. Conzen
The Glucocorticoid Receptor Mediates a Survival Signal in Human Mammary Epithelial Cells
Cancer Res., February 1, 2000; 60(4): 867 - 872.
[Abstract] [Full Text]


Home page
J. Am. Coll. Nutr.Home page
K. N. Prasad, A. Kumar, V. Kochupillai, and W. C. Cole
High Doses of Multiple Antioxidant Vitamins: Essential Ingredients in Improving the Efficacy of Standard Cancer Therapy
J. Am. Coll. Nutr., February 1, 1999; 18(1): 13 - 25.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Kim, O. Bang, Y. Lee, and S. Kang
Production of inducible nitric oxide is required for monocytic differentiation of U937 cells induced by vitamin E-succinate
J. Cell Sci., January 2, 1998; 111(4): 435 - 441.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.